Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Morphic Therapeutic
Biotech
Bayer undergoes leadership shake-up—Chutes & Ladders
Two Bayer pharma execs add new roles. BioNTech hires ex-Novartis’ radioligand head. Arvinas taps former BMS hematology leader as CMO.
Gabrielle Masson
,
Max Bayer
,
Andrea Park
Mar 22, 2024 9:30am
Morphic's stock sinks as data on oral Entyvio rival disappoint
Sep 25, 2023 6:00am
Morphic loses another Big Pharma partner as J&J scraps pact
Jan 23, 2023 7:41am
BIO CEO out the door—Chutes & Ladders
Oct 14, 2022 9:30am
AbbVie ditches Morphic's fibrosis program after 'safety signal'
Feb 24, 2022 3:25pm
AbbVie pulls the trigger on Morphic fibrosis programs, adds $20M
Aug 25, 2020 6:30am